IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 336 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,711,151 | +10.3% | 81,816 | -0.3% | 0.00% | +50.0% |
| Q2 2023 | $3,365,876 | +36.5% | 82,035 | +18.9% | 0.00% | 0.0% |
| Q1 2023 | $2,465,846 | -11.9% | 68,994 | -6.9% | 0.00% | 0.0% |
| Q4 2022 | $2,798,719 | -15.3% | 74,099 | -0.9% | 0.00% | -33.3% |
| Q3 2022 | $3,306,000 | +8.8% | 74,740 | -9.0% | 0.00% | 0.0% |
| Q2 2022 | $3,039,000 | -13.2% | 82,087 | -13.2% | 0.00% | 0.0% |
| Q1 2022 | $3,502,000 | +29.8% | 94,553 | +6.6% | 0.00% | +50.0% |
| Q4 2021 | $2,698,000 | -3.8% | 88,666 | +6.0% | 0.00% | -33.3% |
| Q3 2021 | $2,804,000 | +18.5% | 83,615 | +41.0% | 0.00% | +50.0% |
| Q2 2021 | $2,366,000 | -4.8% | 59,316 | +7.3% | 0.00% | -33.3% |
| Q1 2021 | $2,486,000 | -17.2% | 55,283 | +4.2% | 0.00% | -25.0% |
| Q4 2020 | $3,001,000 | +26.8% | 53,079 | +6.5% | 0.00% | 0.0% |
| Q3 2020 | $2,366,000 | -13.1% | 49,857 | +7.9% | 0.00% | -20.0% |
| Q2 2020 | $2,724,000 | +23.0% | 46,193 | -1.4% | 0.01% | 0.0% |
| Q1 2020 | $2,215,000 | -20.4% | 46,848 | +1.7% | 0.01% | 0.0% |
| Q4 2019 | $2,782,000 | +0.7% | 46,052 | -0.1% | 0.01% | -16.7% |
| Q3 2019 | $2,762,000 | -6.3% | 46,095 | +0.5% | 0.01% | 0.0% |
| Q2 2019 | $2,947,000 | -18.2% | 45,854 | +3.3% | 0.01% | -25.0% |
| Q1 2019 | $3,602,000 | +47.3% | 44,376 | -1.9% | 0.01% | +14.3% |
| Q4 2018 | $2,445,000 | +6.5% | 45,227 | +1.6% | 0.01% | +16.7% |
| Q3 2018 | $2,296,000 | +20.1% | 44,513 | -2.9% | 0.01% | +20.0% |
| Q2 2018 | $1,911,000 | -6.0% | 45,856 | -0.5% | 0.01% | -16.7% |
| Q1 2018 | $2,032,000 | -20.3% | 46,100 | -9.0% | 0.01% | -25.0% |
| Q4 2017 | $2,549,000 | +13.7% | 50,677 | +14.6% | 0.01% | 0.0% |
| Q3 2017 | $2,242,000 | +517.6% | 44,212 | +520.2% | 0.01% | +700.0% |
| Q2 2017 | $363,000 | +21.4% | 7,129 | -8.1% | 0.00% | -50.0% |
| Q1 2017 | $299,000 | -23.5% | 7,758 | -6.0% | 0.00% | -33.3% |
| Q4 2016 | $391,000 | +16.0% | 8,256 | -12.6% | 0.00% | 0.0% |
| Q3 2016 | $337,000 | -61.7% | 9,449 | -54.4% | 0.00% | +50.0% |
| Q1 2016 | $880,000 | -45.9% | 20,699 | -22.4% | 0.00% | -60.0% |
| Q4 2015 | $1,627,000 | – | 26,690 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |